Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet.
about
Dysregulated hepatic expression of glucose transporters in chronic disease: contribution of semicarbazide-sensitive amine oxidase to hepatic glucose uptakePeroxisome proliferator-activated receptors-alpha and gamma are targets to treat offspring from maternal diet-induced obesity in miceTelmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral thPleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular systemDipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice.Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in micePreventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats.Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice.Deficiency of angiotensin type 1a receptors in adipocytes reduces differentiation and promotes hypertrophy of adipocytes in lean mice.Angiotensinogen Exerts Effects Independent of Angiotensin II.Telmisartan prevents high-fat diet-induced hypertension and decreases perirenal fat in ratsAngiotensin-Converting Enzyme 2 Deficiency Aggravates Glucose Intolerance via Impairment of Islet Microvascular Density in Mice with High-Fat Diet.Pleiotropic effects of rosuvastatin on the glucose metabolism and the subcutaneous and visceral adipose tissue behavior in C57Bl/6 miceThe anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing.Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patientsMultifactorial intervention in Type 2 diabetes: the promise of incretin-based therapies.MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice.GLP-1 based therapies: clinical implications for gastroenterologists.From chronic overnutrition to metaflammation and insulin resistance: adipose tissue and liver contributions.Liquid chromatographic determination of linagliptin in bulk, in plasma and in its pharmaceutical preparation.Liquid chromatographic determination of alogliptin in bulk and in its pharmaceutical preparation.Spectrophotometric Methods for the Determination of Linagliptin in Binary Mixture with Metformin Hydrochloride and Simultaneous Determination of Linagliptin and Metformin Hydrochloride using High Performance Liquid Chromatography.Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease.Cocoa flavonoids protect hepatic cells against high-glucose-induced oxidative stress: relevance of MAPKs.Dipeptidyl Peptidase IV Inhibitor Improves Insulin Resistance and Steatosis in a Refractory Nonalcoholic Fatty Liver Disease Patient: A Case Report.Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade.Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivityDoes the enterolactone (ENL) affect fatty acid transporters and lipid metabolism in liver?Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis.Liver damage is not reversed during the lean period in diet-induced weight cycling in mice.Maternal high-fat diet is associated with altered pancreatic remodelling in mice offspring.Metformin Affects Cortical Bone Mass and Marrow Adiposity in Diet-Induced Obesity in Male Mice.Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet.AT1 receptor antagonist induces thermogenic beige adipocytes in the inguinal white adipose tissue of obese mice.Differential actions of PPAR-α and PPAR-β/δ on beige adipocyte formation: A study in the subcutaneous white adipose tissue of obese male mice.Modulation of hypovitaminosis D-induced islet dysfunction and insulin resistance through direct suppression of the pancreatic islet renin-angiotensin system in mice.A critical analysis of three quantitative methods of assessment of hepatic steatosis in liver biopsies.Prevention and treatment effect of evogliptin on hepatic steatosis in high-fat-fed animal models.Rosuvastatin limits the activation of hepatic stellate cells in diet-induced obese mice.Liver and Metformin: Lessons of a fructose diet in mice.
P2860
Q28250220-CCA42E53-7D1A-4FD6-B0CD-75740477A4AFQ28488272-1E0A72DD-3A7D-4ED6-9664-25C7551C3AFBQ28610551-DC02F785-A583-4B30-9E9A-31AF15437ECDQ34062829-C5B8B3C0-BDCC-4735-9BFA-F9BCE47326F4Q34597496-7368EEBD-9EB7-439C-9778-E3ADE6563DE8Q34872407-D45C0CEE-656F-4E5F-92B7-39C47570A22CQ34994537-5A9B1A8D-D0F1-4A4B-B8BA-EEBCBF44AD02Q35860311-2BAB2033-0BED-4550-B5BD-D37961400D9AQ36439462-BB50EFF2-8806-4AC3-A7D0-5E068CB0A10AQ36520564-02E3619C-38FF-4F6F-B546-CE8AE3D116FFQ36680071-B8DB5776-0085-4FD2-A3DD-CCE68144C0BBQ36825669-F289359A-1926-4190-BBF4-05C50461610CQ37028323-35C38721-6063-4B5F-8248-C8A507C31338Q37182800-DD707D1B-C254-4305-AEF7-8724F6F750ABQ37703523-0BC3ED50-06E8-4348-A1CB-FF008957867EQ37828337-08F8651B-F446-4644-BC71-BF89F7FD116AQ38302500-5FCA36E4-EF4D-48B5-91D8-7CADEBB1505FQ38703292-828BF938-716B-4316-84AD-E171C0FEB504Q39414496-812F8EE0-BA6E-4E0C-9BDB-443F4C8EA9B5Q39547298-421807A2-1CDA-4D80-BA27-FC74D0B251F7Q39547413-35FF4E8B-B668-4A31-BC3C-F78BB0213D32Q40394148-D04C5C33-D04D-435E-9623-1F4B7FEEC232Q41457655-000370EB-970B-4768-8E02-245E182AB7ACQ41574088-E0A05044-A32A-4724-B443-5872E83A0691Q42322703-ABAB331F-B9B4-4225-B830-7A344C7A8CAFQ42330055-29F787EC-7B2A-4EFA-8347-0E8155921980Q42825276-F165D24B-61A4-4C02-A361-242997A4886FQ45072672-68D2A86F-94D5-4B91-9FEB-F4D4009FBEC2Q45805661-1AED2522-DB0F-4A32-8ADA-B309A546BA03Q45975745-CFC9ABD9-56D7-4155-8FB4-126BC9A660F8Q46176271-BE382DD3-1C8A-4B44-A43E-ACA091FBBCCAQ46295009-EA123308-B1E3-4299-92E5-B935F7F4E338Q48017506-B07A0516-C405-4DB6-86BA-57EDFBCCA9E2Q48051040-8BC2450E-3ACB-4C2B-BD73-496BA5797B37Q48206129-DB684A17-7A14-404E-8255-C619CBC8EB12Q49031861-74754AE4-F282-4167-A63D-C1321E61502FQ50526595-FC710596-938E-4F4F-A664-C2623FE163F2Q51304729-A2C15C49-71F5-467F-89A9-4FFDEE9FA476Q51479885-C563267B-182C-46FD-99F1-B813F9D271E5Q51750836-1DBEAD17-31DB-4BFF-BF66-B420F2281960
P2860
Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Comparative effects of telmisa ...... e fed on a very high-fat diet.
@en
Comparative effects of telmisa ...... e fed on a very high-fat diet.
@nl
type
label
Comparative effects of telmisa ...... e fed on a very high-fat diet.
@en
Comparative effects of telmisa ...... e fed on a very high-fat diet.
@nl
prefLabel
Comparative effects of telmisa ...... e fed on a very high-fat diet.
@en
Comparative effects of telmisa ...... e fed on a very high-fat diet.
@nl
P2093
P921
P356
P1433
P1476
Comparative effects of telmisa ...... e fed on a very high-fat diet.
@en
P2093
Bianca M Gregório
Fernando S Cardoso-de-Lemos
Laís de Carvalho
Márcia B Aguila
P304
P356
10.1042/CS20100061
P407
P577
2010-06-08T00:00:00Z